Dianne - US: Hailey-Hailey Disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dianne has a family history of Hailey-Hailey disease, a chromosomal defect.

Cindy - US: Hailey-Hailey Disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Cindy from United States who takes LDM for Hailey-Hailey Disease, fibromyalgia and chronic fatigue syndrome. Thank you for joining me, Cindy.

Cindy: Oh, you're welcome.

Low-dose naltrexone: a novel treatment for Hailey-Hailey disease

Br J Dermatol
May 2018
https://pubmed.ncbi.nlm.nih.gov/28991360/

Generalized familial benign chronic pemphigus (Hailey-Hailey disease) treated successfully with low-dose naltrexone

JAAD Case Rep
16 August 2018
https://pubmed.ncbi.nlm.nih.gov/30167446/

Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review

JAMA Dermatol
01 February 2019
https://pubmed.ncbi.nlm.nih.gov/30484835/

The uses of naltrexone in dermatologic conditions

J Am Acad Dermatol
June 2019
https://pubmed.ncbi.nlm.nih.gov/30582992/

Background: Naltrexone in standard and reduced doses is efficacious in many inflammatory and acantholytic disorders.

Objective: We summarized the current data of naltrexone that are relevant to dermatologic practice.

Variable response to low‐dose naltrexone in patients with Darier disease: a case series

J Eur Acad Dermatol Venereol
03 February 2019
https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.15457

Inexpensive Compounding of Low-Dose Naltrexone With Orange Juice

J Am Acad Dermatol
28 March 2019
https://www.practiceupdate.com/content/inexpensive-compounding-of-low-d…

Inexpensive method to formulate low-dose naltrexone (LDN) at any local pharmacy by compounding full-dose naltrexone tablets into orange juice. This formulation can be dispensed with a dropper or mixed into a larger volume of juice.
 

The Use of Naltrexone in Dermatology. Current Evidence and Future Directions

Curr Drug Targets
2019
https://pubmed.ncbi.nlm.nih.gov/30887922/